Welcome to LookChem.com Sign In|Join Free
  • or
1H-Benzimidazole-2-methanol,5-fluoro-(9CI) is a chemical compound belonging to the benzimidazole family, characterized by the presence of a fluorine atom on the 5th carbon of the benzimidazole ring. It has been studied for its potential pharmacological activities, such as anti-cancer properties, and its inhibitory effects on mitochondrial respiration, which may contribute to its therapeutic potential in certain disease conditions. Additionally, it serves as a building block in the synthesis of various pharmaceuticals and organic compounds, making it a versatile compound with potential applications in medicine and organic chemistry.

39811-07-9

Post Buying Request

39811-07-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

39811-07-9 Usage

Uses

Used in Pharmaceutical Industry:
1H-Benzimidazole-2-methanol,5-fluoro-(9CI) is used as a pharmaceutical intermediate for the synthesis of various drugs and organic compounds. Its unique structure and properties make it a valuable building block in the development of new therapeutic agents.
Used in Cancer Research:
1H-Benzimidazole-2-methanol,5-fluoro-(9CI) is used as a potential anti-cancer agent in cancer research. Its pharmacological activities, such as inhibitory effects on mitochondrial respiration, contribute to its therapeutic potential in the treatment of certain types of cancer.
Used in Organic Chemistry:
1H-Benzimidazole-2-methanol,5-fluoro-(9CI) is used as a versatile compound in organic chemistry for the synthesis of various organic compounds. Its unique structure and properties make it a valuable component in the development of new chemical entities with potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 39811-07-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,8,1 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 39811-07:
(7*3)+(6*9)+(5*8)+(4*1)+(3*1)+(2*0)+(1*7)=129
129 % 10 = 9
So 39811-07-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H7FN2O/c9-5-1-2-6-7(3-5)11-8(4-12)10-6/h1-3,12H,4H2,(H,10,11)

39811-07-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol

1.2 Other means of identification

Product number -
Other names (6-fluoro-1H-benzimidazol-2-yl)methanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:39811-07-9 SDS

39811-07-9Relevant academic research and scientific papers

Sustainable Synthesis of 2-Hydroxymethylbenzimidazoles using D-Fructose as a C2 Synthon

Raja, Dineshkumar,Philips, Abigail,Sundaramurthy, Devikala,Chandru Senadi, Gopal

supporting information, p. 3754 - 3759 (2021/10/14)

D-fructose, a biomass-derived carbohydrate has been identified as an environmentally benign C2 synthon in the preparation of synthetically useful 2-hydroxymethylbenzimidazole derivatives by coupling with 1,2-phenylenediamines. Proof of concept was established by synthesizing 23 examples using BF3.OEt2 (20 mol%), TBHP (5.5 M, decane) (1.0 equiv.) in CH3CN at 90 °C for 1 h. The pivotal features of this method include metal-free conditions, short time, good functional group tolerance, gram scale feasibility and the synthesis of benzimidazole fused 1,4-oxazine. Control studies with conventional C2 synthons did not produce the desired product, thus suggesting a new reaction pathway from D-fructose.

Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors

Li, Penghui,Zhang, Wenjin,Jiang, Hong,Li, Yongliang,Dong, Changzhi,Chen, Huixiong,Zhang, Kun,Du, Zhiyun

supporting information, p. 1194 - 1205 (2018/08/01)

In this study, a series of benzimidazole-rhodanine conjugates were designed, synthesized and investigated for their topoisomerase II (Topo II) inhibitory and cytotoxic activities. The results from Topo II-mediated pBR322 DNA relaxation and cleavage assays showed that the synthesized compounds might act as Topo II catalytic inhibitors. Certain compounds displayed potent Topo II inhibition at 10 μM. The cytotoxic activities of these compounds against HeLa, A549, Raji, PC-3, MDA-MB-201, and HL-60 cancer cell lines were evaluated. The results indicated that these compounds exhibited strong antiproliferative activity. A good relationship was observed between the Topo II inhibitory potency and the cytotoxicity of these compounds. The structure-activity relationship revealed that the electronic effects, the phenyl group, and the rhodanine moiety were particularly important for the Topo II inhibitory potency and cytotoxicity.

Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents

Alasmary, Fatmah A.S.,Snelling, Anna M.,Zain, Mohammed E.,Alafeefy, Ahmed M.,Awaad, Amani S.,Karodia, Nazira

supporting information, p. 15206 - 15223 (2015/09/21)

A library of 53 benzimidazole derivatives, with substituents at positions 1, 2 and 5, were synthesized and screened against a series of reference strains of bacteria and fungi of medical relevance. The SAR analyses of the most promising results showed that the antimicrobial activity of the compounds depended on the substituents attached to the bicyclic heterocycle. In particular, some compounds displayed antibacterial activity against two methicillin-resistant Staphylococcus aureus (MRSA) strains with minimum inhibitory concentrations (MICs) comparable to the widely-used drug ciprofloxacin. The compounds have some common features; three possess 5-halo substituents; two are derivatives of (S)-2-ethanaminebenzimidazole; and the others are derivatives of one 2-(chloromethyl)-1Hbenzo[ d]imidazole and (1H-benzo[d]imidazol-2-yl)methanethiol. The results from the antifungal screening were also very interesting: 23 compounds exhibited potent fungicidal activity against the selected fungal strains. They displayed equivalent or greater potency in their MIC values than amphotericin B. The 5-halobenzimidazole derivatives could be considered promising broad-spectrum antimicrobial candidates that deserve further study for potential therapeutic applications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 39811-07-9